AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Top 33%
#1737 out of 5290 analysts
Average Return
+15.38%
Win Rate
25%3 out of 12
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $24.00 | +191.62% | Initiates Coverage On | 5 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | -51.19% | Maintains | 8 months ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | +31.15% | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | +372.38% | Initiates Coverage On | a year ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | +322.54% | Reinstates | a year ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | +426.32% | Reinstates | a year ago |
Engene Therapeutics IncENGN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Xencor IncXNCR | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.